Hypertensive crisis resident survival guide: Difference between revisions

Jump to navigation Jump to search
Line 11: Line 11:
===Common Causes===
===Common Causes===
==Management==
==Management==
{{familytree/start}}
{{familytree | | | | | A01 | | | | | | |A01=<div style="float: left; text-align: left; height: 15em; width: 20em; padding:1em;">'''Characterize the symptoms:''' <br> ❑ CNS - severe headache, dizziness, confusion, weakness/numbness, altered/LOC, difficulty speaking<br> ❑ Eyes - pain, blurred/loss of vision<br> ❑ Cardiopulmonary - chest pain, dyspnea<br>❑ Renal - hematuria, proteinuria, reduced urinary output<br>❑ Others - nausea/vomiting, severe anxiety, nosebleeds</div>}}
{{familytree | | | | | |!| | |}}
{{familytree | | | | | B01 | | |B01=<div style="float: left; text-align: left; height: 25em; width: 20em; padding:1em;">'''Evaluate the patient:''' <br> ❑ History<br>PMH especially HTN<br>Medications - dosages, compliance<br>Recreational drug use - methamphetamine, cocaine, phencyclidine<br> ❑ Physical<br>Blood pessure - both arms<br>Fundoscopy - papilledema, exudates, hemorrhages<br>Neuro exam - mental status, focal neurological deficits<br>Cardiopulmonary - signs of pulmonary edema<br>Abdomen - pulsatile masses, tenderness, bruits<br>Limbs - peripheral pulses</div>}}
{{familytree | | | | | |!| | | | | |}}
{{familytree | | | | | C01 |-| C02 | | |C01=<div style="float: left; text-align: left; height: 20em; width: 20em; padding:1em;">'''Order Labs:'''<br> ❑ CBC<br>❑ BMP + Mg + PO4<br> ❑ Serum uric acid<br> ❑ FLP<br> ❑ FBS <br> ❑ Urinalysis/culture<br> ❑ Urine electrolytes, creatinine, protein<br> ❑ Chest X-ray<br> ❑ EKG, ECHO<br> ❑ Renal USS + doppler</div>|C02=<div style="float: left; text-align: left; height: 22em; width: 20em; padding:1em;">'''Further work-up:'''<br> ❑ TSH, free T3, free T4<br> ❑ Serum cortisol<br> ❑ Serum aldosterone<br> ❑ Serum renin levels<br> ❑ HbA1C<br> ❑ 24-hr urinary catecholamine & metanephrine levels<br> ❑ Serum parathyroid hormone levels<br> ❑ Urine and serum toxicology screen<br> ❑ Urine pregnancy test<br> ❑ CT/MRI<br> ❑ DMSA/DTPA scans (renal scars)<br> ❑ ANA/ESR/CRP/anti-dsDNA/anti-smith/rheumatoid factor/p-ANCA/c-ANCA</div>}}
{{familytree | | | | | |!| | | | |}}
{{familytree | | | | | D01 | | | |D01='''Evidence of end organ damage''' (any of the symptoms above)}}
{{familytree | |,|-|-|-|^|-|-|-|.| | |}}
{{familytree | E01 | | | | | | E02 | |E01='''YES'''|E02='''NO'''}}
{{familytree | |!| | | | | | | |!| | | |}}
{{familytree | F01 | | | | | | F02 | | |F01=Hypertensive emergency<br>('''NB - Treat the patient and not the BP''')|F02=Hypertensive urgency}}
{{familytree | |!| | | | | | | |!| | | |}}
{{familytree | G01 |-|.| | | | G02 | | |G01=<div style="float: left; text-align: left; height: 26em; width: 20em; padding:1em;"><u>'''Admit ICU'''</u><br>Close BP monitoring<br>↓<br>Intra-arterial BP monitoring in severely-ill patients<br>↓<br>Assess volume status - IV N/S if volume depleted to prevent precipitous fall in BP following administration of antihypertensives<br>↓<br>Commence IV antihypertensives based on patient's symptom<br>↓<br>Change IV meds to oral when BP is stable<br>'''NB - Not more than 25% reduction in BP within the 1st hour; when BP is stable, reduce to 160/100-110 mmHg within the next 2-6 hours'''</div>|G02=<div style="float: left; text-align: left; height: 26em; width: 20em; padding:1em;"><u>'''Outpatient/Admit for obeservation'''</u><br>Oral antihypertensives<br>Clinical surveillance within the first few hours of commencing medications<br>'''NB - Gradual BP reduction over 24 - 48 hours'''</div>}}
{{familytree | |!| | |!| | |,|-|^|-|.| | |}}
{{familytree | H01 | |`|-| H02 | | H03 | |H01=<u>'''Special considerations'''</u><br>Malignant hypertension/Hypertensive encephalopathy<br>Cerebrovascular accident<br>Acute pulmonary edema<br>Acute aortic dissection<br>Angina pectoris/Acute MI<br>Sympathetic crisis<br>Preeclampsia/Eclampsia<br>Withdrawal of antihypertensive medication<br>Acute post-op hypertension|H02=Worsening blood pressure|H03=<u>'''Good control'''</u><br>Review old/start new medication<br>'''Modify risk factors'''<br>Close follow-up}}
{{familytree/end}}
==Dos==
==Dos==
==Don'ts==
==Don'ts==

Revision as of 17:11, 9 January 2014

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ayokunle Olubaniyi, M.B,B.S [2]

Definitions

  • Hypertensive urgencies - These are severe elevations in blood pressure with no or minimal evidence of target organ damage.[1] An example is a blood pressure of greater than 160/100 mmHg (stage 2 hypertension) associated with severe headache, shortness of breath, nosebleeds, or severe anxiety.
  • Hypertensive emergencies - These are severe elevations in blood pressure, usually greater than 180/120 mmHg, complicated by evidence of impending or progressive target organ dysfunction. They warrant urgent blood pressure reduction by parenteral agents to prevent or limit target organ damage.[1] This is a clinical diagnosis. Examples include: hypertensive encephalopathy, intracerebral hemorrhage, acute myocardial infarction, e.t.c.

Causes

Life Threatening Causes

Life-threatening causes include conditions which may result in death or permanent disability within 24 hours if left untreated.

Common Causes

Management

 
 
 
 
Characterize the symptoms:
❑ CNS - severe headache, dizziness, confusion, weakness/numbness, altered/LOC, difficulty speaking
❑ Eyes - pain, blurred/loss of vision
❑ Cardiopulmonary - chest pain, dyspnea
❑ Renal - hematuria, proteinuria, reduced urinary output
❑ Others - nausea/vomiting, severe anxiety, nosebleeds
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Evaluate the patient:
❑ History
PMH especially HTN
Medications - dosages, compliance
Recreational drug use - methamphetamine, cocaine, phencyclidine
❑ Physical
Blood pessure - both arms
Fundoscopy - papilledema, exudates, hemorrhages
Neuro exam - mental status, focal neurological deficits
Cardiopulmonary - signs of pulmonary edema
Abdomen - pulsatile masses, tenderness, bruits
Limbs - peripheral pulses
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Order Labs:
❑ CBC
❑ BMP + Mg + PO4
❑ Serum uric acid
❑ FLP
❑ FBS
❑ Urinalysis/culture
❑ Urine electrolytes, creatinine, protein
❑ Chest X-ray
❑ EKG, ECHO
❑ Renal USS + doppler
 
Further work-up:
❑ TSH, free T3, free T4
❑ Serum cortisol
❑ Serum aldosterone
❑ Serum renin levels
❑ HbA1C
❑ 24-hr urinary catecholamine & metanephrine levels
❑ Serum parathyroid hormone levels
❑ Urine and serum toxicology screen
❑ Urine pregnancy test
❑ CT/MRI
❑ DMSA/DTPA scans (renal scars)
❑ ANA/ESR/CRP/anti-dsDNA/anti-smith/rheumatoid factor/p-ANCA/c-ANCA
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Evidence of end organ damage (any of the symptoms above)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
YES
 
 
 
 
 
NO
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Hypertensive emergency
(NB - Treat the patient and not the BP)
 
 
 
 
 
Hypertensive urgency
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Admit ICU
Close BP monitoring

Intra-arterial BP monitoring in severely-ill patients

Assess volume status - IV N/S if volume depleted to prevent precipitous fall in BP following administration of antihypertensives

Commence IV antihypertensives based on patient's symptom

Change IV meds to oral when BP is stable
NB - Not more than 25% reduction in BP within the 1st hour; when BP is stable, reduce to 160/100-110 mmHg within the next 2-6 hours
 
 
 
 
 
 
Outpatient/Admit for obeservation
Oral antihypertensives
Clinical surveillance within the first few hours of commencing medications
NB - Gradual BP reduction over 24 - 48 hours
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Special considerations
Malignant hypertension/Hypertensive encephalopathy
Cerebrovascular accident
Acute pulmonary edema
Acute aortic dissection
Angina pectoris/Acute MI
Sympathetic crisis
Preeclampsia/Eclampsia
Withdrawal of antihypertensive medication
Acute post-op hypertension
 
 
 
 
Worsening blood pressure
 
Good control
Review old/start new medication
Modify risk factors
Close follow-up
 
 
 

Dos

Don'ts

References

  1. 1.0 1.1 Chobanian, AV.; Bakris, GL.; Black, HR.; Cushman, WC.; Green, LA.; Izzo, JL.; Jones, DW.; Materson, BJ.; Oparil, S. (2003). "The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report". JAMA. 289 (19): 2560–72. doi:10.1001/jama.289.19.2560. PMID 12748199. Unknown parameter |month= ignored (help)

Template:WH Template:WS